Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank
Journal of the American Heart Association · 17.02.2026 · 15 (4)
DOI: 10.1161/jaha.125.042361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 17.02.2026. Verfasst von Richard Kazibwe und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine Wake Forest University School of Medicine Winston-Salem NC USA. Hauptthemen laut MEDLINE: Insulin Resistance, Lipoprotein(a), Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Insulin resistance (IR) and lipoprotein(a), Lp(a), are established contributors to cardiovascular disease (CVD) risk. Whether IR modifies the association between Lp(a) and CVD in primary prevention remains uncertain.
Methods
This prospective cohort study included UK Biobank participants without baseline CVD. IR at enrollment was assessed using the triglyceride‐glucose index (TyG). The primary outcome was first major adverse cardiovascular event, defined as peripheral arterial disease, coronary artery disease, myocardial infarction, ischemic stroke, or cardiovascular death. Cox models estimated adjusted hazard ratios (aHRs) with 95% CIs for log‐transformed Lp(a) and TyG, adjusting for each other. Lp(a) was categorized as
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine Wake Forest University School of Medicine Winston-Salem NC USA.
- Hypertension and Vascular Research Center Wake Forest University School of Medicine Winston-Salem NC USA.
- Division of Cardiology Wake Forest University School of Medicine Winston-Salem NC USA.
- Wake Forest University School of Biomedical Graduate Studies Winston-Salem NC USA.
- Department of Medicine Wisconsin College of Medicine Milwaukee WI USA.
- Division of Cardiology Virginia Commonwealth University School of Medicine Richmond VA USA.
ORCID-Profile: Richard Kazibwe, Christopher L Schaich, Parag A Chevli, Jeff A Kingsley, Saeid Mirzai, Juliana H Namutebi, Muhammad Imtiaz Ahmad, Anurag Mehta, Harpreet S Bhatia, Mitchell Paukner, Rishi Rikhi, Erin D Michos, Michael D Shapiro
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Kazibwe, R., Schaich, C. L., Chevli, P. A., Kingsley, J. A., Mirzai, S., Namutebi, J. H., Imtiaz Ahmad, M., Mehta, A., Bhatia, H. S., Paukner, M., Rikhi, R., Michos, E. D., & Shapiro, M. D. (2026). Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank. Journal of the American Heart Association, 15(4). https://doi.org/10.1161/jaha.125.042361
Vancouver
Kazibwe R, Schaich CL, Chevli PA, Kingsley JA, Mirzai S, Namutebi JH, et al. Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank. Journal of the American Heart Association. 2026;15(4). doi:10.1161/jaha.125.042361
BibTeX
@article{Kazibwe2026,
author = {Kazibwe, Richard and Schaich, Christopher L and Chevli, Parag A and Kingsley, Jeff A and Mirzai, Saeid and Namutebi, Juliana H and Imtiaz Ahmad, Muhammad and Mehta, Anurag and Bhatia, Harpreet S and Paukner, Mitchell and Rikhi, Rishi and Michos, Erin D and Shapiro, Michael D},
title = {Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {4},
doi = {10.1161/jaha.125.042361}
}
EUVIMED